Ribose and Sport Performance

Laval University

Status: Completed

Conditions: Sports

Treatments: Other: Ribose; Other: Placebo

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01727479

2012-048

INAF-2012-048

Details and patient eligibility

About

Investigate the acute effect of ribose supplementation on performance and recovery in athletes.

Enrollment: 18 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Men and women
• Training volume > 7hrs/week
• VO2 max > 40 and 45 mg/kg/min (for women and men respectively)
• Otherwise healthy individuals

Exclusion criteria

• Pregnant or breastfeeding women
• Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
• Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
• Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

18 participants in 2 patient groups, including a placebo group

Ribose

Experimental group

Description:

After each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink.

Treatment:

Other: Ribose

Placebo

Placebo Comparator group

Description:

After each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink.

Treatment:

Other: Placebo